X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Pelican BioThermal Opens Dublin Network Station & Service Center

Content Team by Content Team
6th March 2019
in Packaging & Logistic, Press Statements
Pelican BioThermal Opens Dublin Network Station & Service Center

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Pelican BioThermal, the global name in temperature controlled packaging, announces the opening of a new network station and service center in Dublin, Ireland to service, refurbish, repair and condition Pelican BioThermal’s reusable Cr?do on Demand shippers. This new facility puts Pelican BioThermal on track to realize its plan to exceed 100 network stations and drop points for its rental program in 2019.

The Dublin facility is focused on Pelican BioThermal’s Cr?do on Demand program, which provides a high performance, flexible rental option for temperature controlled containers such as Cr?do Cargo, Cr?do™ Xtreme and Cr?do™ Cube. The Cr?do on Demand rental program allows organizations to choose the shipper application that best fits their company’s requirements, logistics profile and budget.

The new Dublin network station and service center is strategically located in Harristown, next to Dublin Airport, and is ideally located to serve the ever-growing pharma industry in Ireland, which is home to some of the world’s leading biotech and pharma companies.

All of the world’s top 10 biopharmaceutical companies and 14 of the world’s top 15 medical technology companies have operations in Ireland according to IDA Ireland (Investment Development Agency), which highlighted how 75 pharmaceutical companies operate in the country where the biopharmaceutical industry has made a capital investment of approximately $10 billion in new facilities during recent years. IDA Ireland added this represents close to the biggest wave of investment in new biotech facilities anywhere in the world. and how Ireland’s pharma, bio and chemistry produce amounts to €39 billion in annual exports.

Dublin is a key hub of manufacturing and distribution for the pharma industry and Ireland is home to some of the largest pharmaceutical and healthcare companies in the world including Lilly, Pfizer, Sanofi, Amgen, Allergan, Alexion, GlaxoSmithKline, Merck and Pramerica.

“Dublin is a key logistics location hub and Ireland’s life sciences sector and bio-pharmaceutical industry is increasing at a rapid rate,” said Dominic Hyde, Pelican BioThermal’s vice president of Cr?do™ on Demand. “As we continue to expand our Cr?do on Demand rental program, the Dublin network station and service center puts customers in closer proximity to more convenient and flexible shipping options.”

The Dublin network station and service center is being staffed by a team of Pelican BioThermal experts to mirror the superior service levels provided at the company’s growing number of network stations and service centers around the globe.

Pelican BioThermal is a division of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.

About Pelican Products
Pelican Products, Inc. is the global leader in the design and manufacture of high performance protective cases, temperature controlled packaging solutions, advanced portable lighting systems and rugged gear for professionals and outdoor enthusiasts. Their products are used by professionals in the most demanding markets including fire safety, law enforcement, defense / military, aerospace, entertainment, industrial and consumer. Pelican™ products are designed and built to last a lifetime. The company operates in 21 countries, with 22 international sales offices and six manufacturing facilities around the globe. In Europe, the company does business under the name Peli Products, S.LU. For more information, visit www.pelican.com or www.behrmancap.com

About Pelican BioThermal
Pelican BioThermal LLC offers the widest range of thermally protected, temperature-controlled packaging and service solutions to the global life sciences industry. The company’s products ensure that delicate biological materials arrive intact and effective, despite exterior environments. Pelican BioThermal is dedicated to developing innovative products designed to fulfill the complex needs of the global life sciences industry. The company’s efforts have received recognition including the U.S. Army’s Greatest Inventions and the Made in Minnesota Manufacturing award for supply chain innovators. The company’s customers benefit from its extensive expertise in ensuring that temperature stability is maintained throughout the distribution chain. The company also offers a complete portfolio of services and software to support end-to-end temperature-controlled packaging asset management. In Europe, the company does business under the name Peli BioThermal Limited. For more information, visit pelicanbiothermal.com

Previous Post

The first WuXi Healthcare Forum opens in Shanghai

Next Post

Aprecia and CMIC have established an agreement to bring 3DP pharmaceutical products to Japan

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
Aprecia and CMIC have established an agreement to bring 3DP pharmaceutical products to Japan

Aprecia and CMIC have established an agreement to bring 3DP pharmaceutical products to Japan

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In